Answers are grounded in this paper and cite their sources.
Summary Objective and design We explored the cross‐sectional and longitudinal associations of thyroid function within the normal range with cardiovascular disease (CVD) risk factors and adiposity measures. Patients and measurements A total of 3483 (50·4% women) participants for the cross‐sectional CVD study and 1630 (41·2% women) participants for the cross‐sectional body composition substudy were drawn from the Framingham Third Generation Exam 1; 2912 participants (50·1% women) for the longitudinal CVD study and 713 participants (35·9% women) for the longitudinal body composition substudy were drawn from the Framingham Third Generation Exams 1–2. Thyroid function was assessed by thyrotropin [thyroid‐stimulating hormone (TSH)] and free thyroxine (fT4) concentrations within the reference range at Exam 1. The associations between thyroid function and CVD risk factors were modelled via multivariable‐adjusted regression models. Multivariable adjustment included age, sex, current smoking, postmenopausal status and BMI. Results Cross‐sectionally, higher TSH concentration was associated with increased odds of hypertriglyceridaemia [odds ratio (OR)=1·10], and higher BMI (β = 0·19 kg/m2), total cholesterol (β = 0·05 mmol/l), triglycerides (β = 0·0006 mmol/l) and subcutaneous adipose tissue (SAT) volume (β = 38·8 cm3) (all P < 0·05). Cross‐sectionally, fT4 was inversely associated with metabolic and adiposity‐related CVD risk factors, including obesity (OR = 1·17), hypertriglyceridaemia (OR = 1·09), BMI (β = 0·42 kg/m2), total cholesterol (β = 0·05 mmol/l), triglycerides (β = 0·0002 mmol/l), visceral adipose tissue (VAT) volume (β = −20·7 cm3) and attenuation (0·17 HU) and VAT/SAT ratio (β = −0·01) (all P < 0·05). However, during 6·1 years of follow‐up, baseline TSH and fT4 levels were not longitudinally associated with CVD risk factors and adiposity measures. Conclusions Thyroid function within the normal range is cross‐sectionally, but not longitudinally, associated with CVD risk factors and adiposity measures.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: